ID | Term | Allele | Alleles | Background | Color Key |
---|
MP:0002023 | B cell derived lymphoma |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0006082 | CNS inflammation |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1/J | color key |
MP:0002024 | T cell derived lymphoma |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C.B6-Prf1 | color key |
MP:0010766 | abnormal NK cell physiology |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0010766 | abnormal NK cell physiology |
Prf1tm1Tsc |
Prf1tm1Tsc/Prf1tm1Tsc | 129X1.129S2-Prf1 | color key |
MP:0004924 | abnormal behavior |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1/J | color key |
MP:0000188 | abnormal circulating glucose level |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | NOD.B6-Prf1 | color key |
MP:0003009 | abnormal cytokine secretion |
Prf1tm1Clrk |
Prf1tm1Clrk/Prf1tm1Clrk | C.129S7(B6)-Prf1 | color key |
MP:0003699 | abnormal female reproductive system physiology |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0001845 | abnormal inflammatory response |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0002442 | abnormal leukocyte physiology |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0003945 | abnormal lymphocyte physiology |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1/J | color key |
MP:0003448 | altered tumor morphology |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C.B6-Prf1 | color key |
MP:0001847 | brain inflammation |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1/J | color key |
MP:0006414 | decreased T cell apoptosis |
Prf1tm1Tsc |
Prf1tm1Tsc/Prf1tm1Tsc | 129X1.129S2-Prf1 | color key |
MP:0002942 | decreased circulating alanine transaminase level |
Prf1tm1Tsc |
Prf1tm1Tsc/Prf1tm1Tsc | involves: 129S2/SvPas | color key |
MP:0003339 | decreased pancreatic beta cell number |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | NOD.B6-Prf1 | color key |
MP:0004804 | decreased susceptibility to autoimmune diabetes |
Prf1tm1Clrk |
Prf1tm1Clrk/Prf1tm1Clrk | involves: 129S7/SvEvBrd * BALB/c * NOD | color key |
MP:0004804 | decreased susceptibility to autoimmune diabetes |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | NOD.B6-Prf1 | color key |
MP:0002411 | decreased susceptibility to bacterial infection |
Prf1tm1Tsc |
Prf1tm1Tsc/Prf1tm1Tsc | involves: 129S2/SvPas | color key |
MP:0010308 | decreased tumor latency |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0005079 | defective cytotoxic T cell cytolysis |
Prf1tm1Clrk |
Prf1tm1Clrk/Prf1tm1Clrk | involves: 129S7/SvEvBrd * C57BL/6 | color key |
MP:0005079 | defective cytotoxic T cell cytolysis |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0005079 | defective cytotoxic T cell cytolysis |
Prf1tm1Tsc |
Prf1tm1Tsc/Prf1tm1Tsc | involves: 129S2/SvPas | color key |
MP:0000921 | demyelination |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1/J | color key |
MP:0005070 | impaired natural killer cell mediated cytotoxicity |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0005070 | impaired natural killer cell mediated cytotoxicity |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | involves: BALB/c * C57BL/6 | color key |
MP:0005070 | impaired natural killer cell mediated cytotoxicity |
Prf1tm1Tsc |
Prf1tm1Tsc/Prf1tm1Tsc | involves: 129S2/SvPas | color key |
MP:0001829 | increased activated T cell number |
Prf1tm1Clrk |
Prf1tm1Clrk/Prf1tm1Clrk | C.129S7(B6)-Prf1 | color key |
MP:0008566 | increased interferon-gamma secretion |
Prf1tm1Clrk |
Prf1tm1Clrk/Prf1tm1Clrk | C.129S7(B6)-Prf1 | color key |
MP:0008660 | increased interleukin-10 secretion |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0002022 | increased lymphoma incidence |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C.B6-Prf1 | color key |
MP:0002022 | increased lymphoma incidence |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0008873 | increased physiological sensitivity to xenobiotic |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | NOD.B6-Prf1 | color key |
MP:0009763 | increased sensitivity to induced morbidity/mortality |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0009763 | increased sensitivity to induced morbidity/mortality |
Prf1tm1Tsc |
Prf1tm1Tsc/Prf1tm1Tsc | 129X1.129S2-Prf1 | color key |
MP:0002412 | increased susceptibility to bacterial infection |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0002406 | increased susceptibility to infection |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0005027 | increased susceptibility to parasitic infection |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0002418 | increased susceptibility to viral infection |
Prf1tm1Clrk |
Prf1tm1Clrk/Prf1tm1Clrk | C.129S7(B6)-Prf1 | color key |
MP:0002418 | increased susceptibility to viral infection |
Prf1tm1Clrk |
Prf1tm1Clrk/Prf1tm1Clrk | involves: 129S7/SvEvBrd * C57BL/6 | color key |
MP:0002418 | increased susceptibility to viral infection |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0002418 | increased susceptibility to viral infection |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1/J | color key |
MP:0003721 | increased tumor growth/size |
Prf1tm1Tsc |
Prf1tm1Tsc/Prf1tm1Tsc | 129X1.129S2-Prf1 | color key |
MP:0009828 | increased tumor latency |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C.B6-Prf1 | color key |
MP:0008560 | increased tumor necrosis factor secretion |
Prf1tm1Clrk |
Prf1tm1Clrk/Prf1tm1Clrk | C.129S7(B6)-Prf1 | color key |
MP:0004031 | insulitis |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | NOD.B6-Prf1 | color key |
MP:0002027 | lung adenocarcinoma |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C.B6-Prf1 | color key |
MP:0002169 | no abnormal phenotype detected |
Prf1tm1Geno |
Prf1tm1Geno/Prf1tm1Geno | involves: C57BL/6 | color key |
MP:0005580 | periinsulitis |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | NOD.B6-Prf1 | color key |
MP:0002083 | premature death |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C57BL/6-Prf1 | color key |
MP:0002032 | sarcoma |
Prf1tm1Sdz |
Prf1tm1Sdz/Prf1tm1Sdz | C.B6-Prf1 | color key |